Company Overview and News
Voya Financial, Inc. (VOYA - Free Report) is the owner and operator of a retirement investment and insurance company. The Zacks Consensus Estimate for its current year earnings has been revised 0.5% downward over the last 30 days.
Good day, ladies and gentlemen. Welcome to Vista Gold’s 2017 Financial Results and 2018 Corporate Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. Today is Friday, March 9, 2017. It is now my pleasure to introduce Vista’s President and CEO and your host, Mr. Fred Earnest. Please go ahead, Mr. Earnest.
Vista Gold Corp. (AMEX:VGZ) has 28 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28,963,976 shares. Largest shareholders include Sun Valley Gold Llc, Global Strategic Management Inc, Loews Corp, California Public Employees Retirement System, Wells Fargo & Company/mn, Morgan Stanley, Goldman Sachs Group Inc, Sprott Inc.
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).
* Vista Gold - units & co entered into deal to option interest in Guadalupe de los Reyes gold & silver project in Sinaloa to Minera Alamos Source text for Eikon: Further company coverage:
Prospectus Supplement to Prospectus dated July 5, 2017 Filed Pursuant to Rule 424(b)(2) Registration No. 333-218979 6,514,625 Common Shares underlying Warrants VISTA GOLD CORP. This prospectus supplement and the accompanying base prospectus relate to: (i) up to 6,514,625 common shares (which we refer to herein as “Warrant Shares”) of Vista Gold Corp. (which we refer to herein as “Vista,” the “Company,” “we,” or “us”) issuable from time to time upon the exercise of 6,514,625 whole commo
Good day, ladies and gentlemen. Welcome to today’s Vista Gold Second Quarter 2017 Financial Results and Quarterly Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today and it is Wednesday, August 9, 2017. It is now my pleasure to introduce Vista’s President and CEO and your host, Mr. Fred Earnest. Please go ahead.
Q2-17 results FINAL (jfe rev 3) EXHIBIT 99.1 7961 Shaffer Parkway Suite 5 Littleton, CO 80127 Phone: 720-981-1185 Fax: 720-981-1186 Trading Symbol: VGZ Toronto and NYSE MKT Stock Exchanges __________________ NEWS _________________ Vista Gold Corp. Announces Second Quarter 2017 Results and Recent Corporate Highlights Denver, Colorado, August 7, 2017 - Vista Gold Corp.
Q2 17 081017 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: August 7, 2017 (Date of earliest event reported) VISTA GOLD CORP. (Exact Name of Registrant as Specified in Charter) British Columbia, Canada (State or Other Jurisdiction of Incorporation) 1-9025 (Commission File Number) Not Applicable (IRS Employer Identification No.
DENVER, Aug. 7, 2017 /PRNewswire/ -- Vista Gold Corp. (the "Company," "we" or "our") (NYSE American: VGZ) (TSX: VGZ) today announced its unaudited financial results for the second quarter ended June 30, 2017. Management's quarterly conference call to discuss these results is scheduled for 2:30 p.m. MDT on August 9, 2017. The Company's unaudited financial statements, Management's Discussion and Analysis together with other important disclosures can be found in the Company's Quarterly Report on Form 10-Q, filed on August 4, 2017 with the U.
Vista Gold Corp. 7961 Shaffer Parkway, Suite 5 Littleton, CO 80127 July 3, 2017 Via EDGAR Securities and Exchange Commission ATTN: Mr. Jonathan Burr 100 F Street, NE Washington, D.C. 20549 Re: Vista Gold Corp. – Request for Acceleration Registration Statement on Form S-3 Filed on June 26, 2017 File No. 333-218979 Ladies and Gentlemen: On behalf of Vista Gold Corp., we hereby respectfully request that the Commission accelerate the effectiveness of the above-referenced Registration
Mail Stop 3561 June 30, 2017 Via E-Mail Frederick Earnest Chief Executive Officer Vista Gold Corp. Suite 5, 7961 Shaffer Parkway Littleton, CO 80127 Re: Vista Gold Corp. Registration Statement on Form S-3 Filed June 26, 2017 File No. 333-218979 Dear Mr. Earnest: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...